Evidence map›Paper›PMID 37395412›Full record

ArticleNucleic acids research2023

Simultaneous multifunctional transcriptome engineering by CRISPR RNA scaffold.

Zukai Liu, Nathaniel Jillette, Paul Robson, Albert Wu Cheng

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Precision Transcriptome Editing.ACS synthetic biology · 2024
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Zukai LiuThe Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.
Nathaniel JilletteThe Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.
Paul RobsonThe Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.
Albert Wu ChengThe Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.ORCID 0000-0003-2653-5743
Jackson Laboratory · US

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
Induction of melanoma immunity by dendritic cell subsetsP01CA084512 · NCI · ROCKEFELLER UNIVERSITY · PI BANCHEREAU, JACQUES F · 2000 to 2010
$12.1M
Modular Platform for Combinatorial Epigenome ManipulationR01HG009900 · NHGRI · JACKSON LABORATORY · PI ADAMS, MARK D · 2018 to 2022
$3.7M
NCI NIH HHS P01 CA084512NCI NIH HHS P30 CA034196NHGRI NIH HHS R01 HG009900NHGRI NIH HHS R01-HG009900
6 · The paper itself

Abstract

RNA processing and metabolism are subjected to precise regulation in the cell to ensure integrity and functions of RNA. Though targeted RNA engineering has become feasible with the discovery and engineering of the CRISPR-Cas13 system, simultaneous modulation of different RNA processing steps remains unavailable. In addition, off-target events resulting from effectors fused with dCas13 limit its application. Here we developed a novel platform, Combinatorial RNA Engineering via Scaffold Tagged gRNA (CREST), which can simultaneously execute multiple RNA modulation functions on different RNA targets. In CREST, RNA scaffolds are appended to the 3' end of Cas13 gRNA and their cognate RNA binding proteins are fused with enzymatic domains for manipulation. Taking RNA alternative splicing, A-to-G and C-to-U base editing as examples, we developed bifunctional and tri-functional CREST systems for simultaneously RNA manipulation. Furthermore, by fusing two split fragments of the deaminase domain of ADAR2 to dCas13 and/or PUFc respectively, we reconstituted its enzyme activity at target sites. This split design can reduce nearly 99% of off-target events otherwise induced by a full-length effector. The flexibility of the CREST framework will enrich the transcriptome engineering toolbox for the study of RNA biology.

Indexed as

CRISPR-Cas SystemsRNAGene EditingRNA Processing, Post-TranscriptionalRNA SplicingTranscriptomeRNA

Identifiers

PMID37395412
PMCPMC10415119
OpenAlexW4382918512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.